Birdwatch Note
2022-11-30 14:43:22 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The headline omits text including that Ivermectin cannot be used in humans for COVID until further testing and clinical trials have been completed for human dosing. The use of Ivermectin remains unproven, depends on pre-clinical testing and clinical trials. https://www.thepharmaletter.com/article/ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds https://factcheck.afp.com/http%253A%252F%252Fdoc.afp.com%252F9DG443-1 https://www.abc.net.au/news/2020-04-04/monash-researchers-hopes-for-coronavirus-drug-treatment-warning/12121578
Written by CD4462E0ADDDC34E6C49FD22579E48A59F780AAEB9CE2CA216C1301497E6C8A5
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1597758757798547457
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1597964508273704963
- noteId - 1597964508273704963
- participantId - CD4462E0ADDDC34E6C49FD22579E48A59F780AAEB9CE2CA216C1301497E6C8A5
- noteAuthorParticipantId -
- createdAtMillis - 1669819402175
- tweetId - 1597758757798547457
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The headline omits text including that Ivermectin cannot be used in humans for COVID until further testing and clinical trials have been completed for human dosing. The use of Ivermectin remains unproven, depends on pre-clinical testing and clinical trials. https://www.thepharmaletter.com/article/ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds https://factcheck.afp.com/http%253A%252F%252Fdoc.afp.com%252F9DG443-1 https://www.abc.net.au/news/2020-04-04/monash-researchers-hopes-for-coronavirus-drug-treatment-warning/12121578
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2022-11-30 14:43:22 UTC (1669819402175) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
CD4462E0ADDDC34E6C49FD22579E48A59F780AAEB9CE2CA216C1301497E6C8A5 |
Note Ratings
rated at | rated by | |
2022-11-30 18:39:41 -0600 | 005D3079642BDAF7DE4E03D4941DA4AA612224D99A7CA3FACA12854249AA2873 | Rating Details |
2022-11-30 17:55:41 -0600 | 05D25BB24A0FE12D17A8349E416AA3B31E2E34A8C1ED6DC8D64D67AEA566AA96 | Rating Details |
2022-11-30 17:33:01 -0600 | 0A12134A8BF627B40079252B246D8DBEA31AB54B999E1AC5E9B1D85488A211CF | Rating Details |
2022-11-30 20:40:44 -0600 | 0A5B082A68C6F3150A476B9F59E72F0707D89B0432BF7DF9388190A7045E7C9D | Rating Details |
2022-11-30 17:24:03 -0600 | 0D72E8890AC0C9EF5D530D3E51F3C2601E501131E46A2307D4D24D808DD08362 | Rating Details |
2022-12-02 08:06:31 -0600 | 0E3F6EB4AAF7233033251BACE0F0325D12DBDA5E1D67354D15807134017D9D96 | Rating Details |
2022-12-01 12:43:37 -0600 | 0F216099A339D0D32175FD908411C8EC678482567B79B561C8EBB42BC1921AE3 | Rating Details |
2022-11-30 17:39:06 -0600 | 10AECDF8B951AB1680C88A987EC3279B3D1BBD413B328CB35623EC93A881A5EC | Rating Details |
2022-11-30 17:31:05 -0600 | 131DB9C4E37DDC475C5DB0A09D411063062575BFE9592593E730A12C51C84595 | Rating Details |
2022-11-30 16:22:27 -0600 | 1336446E52147E5398266C3CB3FCB8413DA3543F8852EB9FACA1B561C812C9E5 | Rating Details |
2022-11-30 18:30:42 -0600 | 13CAB85A55608D62F517BB4B993DEC375606F8798EFB79E82F29DA0D5DFE078E | Rating Details |
2022-11-30 17:57:34 -0600 | 14F852B956BD74A1ED2804F4381BA98E1B75C873B341843561C7FCF3BA1F449A | Rating Details |
2022-11-30 18:10:40 -0600 | 15714D7C05B274762113E1F011588745EC3877363382E382B7CF6B83E4CC67C4 | Rating Details |
2022-11-30 17:50:54 -0600 | 161FCB09AC1BADAD561BB1A8BEE9944A6339CA467230F1279055CD9673A0C285 | Rating Details |
2022-11-30 18:13:30 -0600 | 1BECAB5FB5B09CB3910AE6AAD06E1EE4655BE1C73354DB426B18996DDC59FF80 | Rating Details |
2022-11-30 18:09:31 -0600 | 1DD71840EDED0C71F5858779930EAEF75BC718AB77E3C5518486E13A2F8B6B06 | Rating Details |
2022-11-30 18:17:06 -0600 | 24722D9378F3291114268646C3ACDC7BBE8D19593B8170DFF4DB9BE42F12BBCF | Rating Details |
2022-11-30 17:44:40 -0600 | 27A935087EB8674166936C1B8A9968185EF713B52E4131C8E388F3DDADFED2CF | Rating Details |
2022-11-30 18:44:07 -0600 | 27C642072837380A04AC0A92BB5A3D4C9E02383B932320005A6F0ACC413E8473 | Rating Details |
2022-11-30 17:37:12 -0600 | 292462FE02386BF8DA52B6E41A1EC47C5802A46ECEB0F4FCC9C6E4742327D2D2 | Rating Details |
2022-11-30 17:24:35 -0600 | 2B50976A9769BB89BD7995630590A7003CD5CEE63E8F8F1D4967C437D5B8CB45 | Rating Details |
2022-11-30 18:28:59 -0600 | 2E5FFDD4A2FE4393EA12C2DB802C613CFF5CEF1C7E21354CDFE6D278F02BD074 | Rating Details |
2022-11-30 18:22:40 -0600 | 2FD546AE1C90ADAB899845F1C760102FB302A7612A378DF4614035ABC3A0D8EA | Rating Details |
2022-11-30 17:18:35 -0600 | 31F2E944B69749081C110466887C8B7639EE357B5515AC2B34C86CD1CE114E43 | Rating Details |
2022-11-30 17:22:59 -0600 | 3437C70B303DFB779540D71BAD1927181691424AAD1916C79E362F4332FD0626 | Rating Details |
2022-11-30 18:03:59 -0600 | 382EB8BB8ED38E3074257CCD428FB64561130F1A02C5C8588EB04689CAFB7AFE | Rating Details |
2022-11-30 13:41:29 -0600 | 3922021E2B4C1A4B610B8FAFE0447925B4441B7A397CBAE1E446B9DE65C2A8E3 | Rating Details |
2022-11-30 18:00:16 -0600 | 392B52071F003831DC41A5A75967C08BECE01D156D7C254B85C09FC4A4BBA562 | Rating Details |
2022-11-30 17:47:45 -0600 | 3ACA8930F8F8E1F8FCBF9A6E954BBA38F9F8817A4A70C4D861DA916BFC800054 | Rating Details |
2022-11-30 18:26:07 -0600 | 3B2AF89DBCD1E694B82D673CB73DFDD7B87DE49C123765B1EEF6A81DE687D78C | Rating Details |
2022-11-30 18:09:58 -0600 | 3D509B30A339AD054DB126A8A750605C582747D64D31D002DFF9C2FC3BF25B54 | Rating Details |
2022-11-30 17:51:25 -0600 | 3D9CE0383CFF92F44DC9E7E2573FD5D7E54D79860BD3C40FD07722C5DB671FD1 | Rating Details |
2022-11-30 17:37:47 -0600 | 3DD7D1F2CB289820556E0BA813B3DECAE65B67D37F12458194460FFD3FB7972F | Rating Details |
2022-11-30 18:04:16 -0600 | 4045C453DDBDEAEC703AC7CDD1FCCAA49743FD0FA98D9190BC401802F4990C4E | Rating Details |
2022-11-30 17:33:26 -0600 | 40C8362000D0C9B480AB8149C9A86DCD32C5A1B4BDA09EEE76DDEBDA774609B1 | Rating Details |
2022-11-30 17:40:51 -0600 | 40E7E442F1C21D591502C842409A39FF3AE339222C36717A78866FA5136B1468 | Rating Details |
2022-11-30 17:45:52 -0600 | 4671876B9EDF663FC7D45DEAC0490751C752525C5ACB0757C2F5FB1259736503 | Rating Details |
2022-11-30 17:51:15 -0600 | 4A207DA9990A8175CC0DA46AB22BE94275D44E16FB98BAB6CDA83BCE149CA59B | Rating Details |
2022-11-30 17:49:55 -0600 | 4C72FF201E21DE33E2FD1118AB9708E7D67F30F145FA37C8C913B5F52462ED3A | Rating Details |
2022-11-30 17:46:57 -0600 | 4D8C4B25E58BF8FDCE60F095DC1534C2CC53FA5887A670869852A92B17C56420 | Rating Details |
2022-11-30 17:25:53 -0600 | 4DF4C401936A18108ED6A3ADB9A0780EE55662A905CA0DA56A9E356C331C8D35 | Rating Details |
2022-11-30 17:07:41 -0600 | 547B46B38A1CB3060240F9F561852ADB212E08AA27CDAE1D9BE8DDCD9A5D2518 | Rating Details |
2022-11-30 18:04:15 -0600 | 597BDEF06D5295E525F92FE0EFDCA36D1FDC38026A5E82D997A4B4B78AC3A1F7 | Rating Details |
2022-12-01 01:37:05 -0600 | 59FA15B71D8C02DCCCADA12BC80429389147D89D428FFACABB8DF6A66B2CE299 | Rating Details |
2022-11-30 17:45:41 -0600 | 5A5E3FD5B4AEA0F70E3EC42303842D1138840F9B44D3DC2B4E691007675B7047 | Rating Details |
2022-11-30 10:30:50 -0600 | 5C4D11DBA4F31BABB881CF93371BB9E3BE9698ED20401EB203B64F13F0E91561 | Rating Details |
2022-11-30 17:25:38 -0600 | 61FF48B6D50CAEEC80BEE001C98146826EF4336D58D8332C0209323655059A5A | Rating Details |
2022-11-30 17:35:15 -0600 | 6394B2D2414396ED2D02DE310CE2DB3174AE8C0CAFF0E16560A4FA3AAB35B30E | Rating Details |
2022-11-30 17:30:18 -0600 | 63A094747A67BCC9179D4AE96E575B1CF0DF42E8876914F5D3DF07FDED8FBD97 | Rating Details |
2022-11-30 17:49:24 -0600 | 642E675694A2100BF84794D168261668C256BFFE2805299283C5CD544490AA37 | Rating Details |
2022-11-30 18:10:24 -0600 | 68271F243C62D483F799012546DB505AD95E66F59D7AD3D4A47FF94A630EDAC0 | Rating Details |
2022-11-30 18:54:59 -0600 | 690C41D10F4F8021FEC83AE2ED3D10A7CBB768BC862F5C9691C05081AADE583D | Rating Details |
2022-11-30 18:02:44 -0600 | 6B8C287E76E2C23D3E1B6B779BB6034087EE278C1C81CC134D523A30AE9D656A | Rating Details |
2022-11-30 17:28:03 -0600 | 6BE237C0A508809C3F2FE2E38DE6158FC210DD760DAED11B986F98AF4997E9D5 | Rating Details |
2022-12-01 08:52:34 -0600 | 6E76CE163012825DBEB32807367391AE32594E8CAB1349174CD7BD5FFCD9F591 | Rating Details |
2022-11-30 17:49:11 -0600 | 6F1CF3F177748F90CEE8FDA5ED249AA9C74A6314F949A0A094D2FE11C27B1B05 | Rating Details |
2022-11-30 17:58:25 -0600 | 6FC95EDD3C9FCD2E80E7169D21AE43C979C7B61A4BF4674DF6E8D4D9290627C7 | Rating Details |
2022-11-30 20:19:30 -0600 | 7051FDE12D7370A9D5A81D4ADF480A649998C9F2EDA84E2EA22C1367736036A7 | Rating Details |
2022-11-30 09:31:14 -0600 | 70C181B24233FF8251A370E67F314FF2678F046BCC2BD211A42D44AC787BC7DC | Rating Details |
2022-11-30 17:43:17 -0600 | 73E313E3E609BD537C9910C991280EDCD0E5E365544A8DE15F4C16E6D7B722E5 | Rating Details |
2022-11-30 17:47:32 -0600 | 75EAC72198E5666424F2AF8209092A0510170097E23B20FC35F795B2804BC9FC | Rating Details |
2022-11-30 17:22:59 -0600 | 77ADFA2A12B57E1BF264F4E1174BAB3DA4DFA5BAF3B22F5B0EF2613446FB5302 | Rating Details |
2022-11-30 17:36:34 -0600 | 79FCF532A213BA7BDC3B479F56B79BF6E20E7F044E469A9D81701EDF509AF879 | Rating Details |
2022-11-30 17:37:16 -0600 | 7B45B0ABD7274AB587950D05D48E1447AD1FC0B6862B60EE9E1E8E60D2E858F0 | Rating Details |
2022-11-30 22:26:35 -0600 | 7BD0400C81C023A216961124BAA56A5AD5E66E315C72382F8D9B9F5908924672 | Rating Details |
2022-11-30 17:25:22 -0600 | 7D5B3697DEECBDCCD06020B8210098DCD2EE515B4B42CBE9678A253A897C6063 | Rating Details |
2022-12-01 10:32:23 -0600 | 7DAF7E766C91C4681BD9E35A65ED1244CD021FD7E551BF6AB85D6DF31D7EAC10 | Rating Details |
2022-12-01 08:21:56 -0600 | 95F7A3EB2A168CA64B3E872F9D7C23876AA4B35589501BF82B47671AC4AA3217 | Rating Details |
2022-11-30 20:55:42 -0600 | 96259C16C38458FE7A8A6C293A8049357F7D3EC2D0F557E58FD8034ED6400C1F | Rating Details |
2022-11-30 17:16:02 -0600 | 972F10FFA7C07689676B25EC46A5B5A815F19570A7C54D3FD3F59F725F37B81F | Rating Details |
2022-11-30 18:16:55 -0600 | 99190A82CE39BADEA9B2BEA8F56CABF978128A565AFCF2ECA3971589E99E5AED | Rating Details |
2022-11-30 17:30:00 -0600 | 9A4197A3D8DF7514DBC16A6318594565F6E734BE005C10AA2254B3658300624E | Rating Details |
2022-11-30 18:21:41 -0600 | 9F8B8ECC25B77B2EDE6416CC064252EE8BE499F10C8AE165EA6928260500B6D2 | Rating Details |
2022-12-01 09:50:38 -0600 | A0B58341951F910E220D2AE0080B908B883C7499CF480E4CE1DA476769955D31 | Rating Details |
2022-11-30 18:51:04 -0600 | A0DA2C6EE0F1B7F585B9F56A3F5CEB2B9A08E75FA2CE0D65636A38D99CB51842 | Rating Details |
2022-12-01 09:08:01 -0600 | A4125342C664F246ADA997FDA2127A9A36AF81549808882E6E2B96C0929DDED7 | Rating Details |
2022-12-01 10:55:11 -0600 | A86C0F99F8EC1ADC946170050AEB69905C4F1D1514244E999455FF71F57C7151 | Rating Details |
2022-11-30 18:02:41 -0600 | A93586EA0AC98003942CD8FA65420FC1C0D112DCDB40D023CF7F5CC914BBA41F | Rating Details |
2022-11-30 17:37:22 -0600 | AE329E790D243C183BB2E27C9622B55AFC1A7657082580A50535A8F46D800BFD | Rating Details |
2022-11-30 18:04:38 -0600 | AE691B23102CFA9D57294B2196709B841E2C8962CB3EB4595AF78ACDEF599DBA | Rating Details |
2022-11-30 17:56:46 -0600 | AF3F4928D4AB96D026E045A1DF8B6E68726139214D2FEDD61FD0CFAD14B180D7 | Rating Details |
2022-11-30 17:34:58 -0600 | AF99DA26182D7A85F5D98675CAAF3D83C39D0EEA82249EF07E905AEA8E8C41C1 | Rating Details |
2022-11-30 17:54:55 -0600 | BD6786CD4F852FB39AD775B7C8C36D03F31567173BB8DA0AAAF9F75E8BFB5343 | Rating Details |
2022-11-30 18:07:16 -0600 | BF4D48E8B13975A4D4B3B4BCBB426BF4CC59A95BEB1A7D02756782C8AA757169 | Rating Details |
2022-11-30 11:26:32 -0600 | C02ECC52E5D398AC7BD1550D6E659F4A42684AC860345B288926E487B3373AA9 | Rating Details |
2022-12-01 07:53:13 -0600 | C114AE7443E7B8F37927077AEBFF939CF496CCF90C3DC24ACA95F015E2AB6DC7 | Rating Details |
2022-11-30 19:41:56 -0600 | C2F769E707822384F16AF01237B27C9F2F36B32D983C75F6EA9B436AD50087B4 | Rating Details |
2022-11-30 17:55:11 -0600 | C38E8EBA44E2B47A87402910589FB939E686F766AF8D525700D31239FD691F63 | Rating Details |
2022-11-30 18:11:57 -0600 | C44E17349BB0649312BBD163829B10D61FA2D5741F4D157F04DD471CF5BC896A | Rating Details |
2022-11-30 17:29:39 -0600 | C467E818CA54E09CD9704ACCAC5D3997E99BCA7DC54A3C475F00C985D61033C2 | Rating Details |
2022-11-30 17:58:56 -0600 | C5556A5CADDC01A4101B46C55101B2BBC415D68891C8E99396CB9616CB73E23D | Rating Details |
2022-11-30 16:17:53 -0600 | C779C8A778087B7527F981A929C6C559501EB2A61D453746C9E85033BE33F19C | Rating Details |
2022-11-30 18:28:07 -0600 | C94F201F97A718EB5C842ABBF182E1996C2EE42E81E02545398E156335DC8D48 | Rating Details |
2022-11-30 17:46:18 -0600 | CA4122B3068655DBC251A5C8A5D0DD87A9FF033F38465FE69C9C1704557692C5 | Rating Details |
2022-11-30 17:22:15 -0600 | CA4F4E57DC00B721A2D03D14DD43E9073E7549F8F783C28A6C1F5324ADD080C1 | Rating Details |
2022-11-30 18:12:29 -0600 | CA5CF45E74642D18F379ACA52AA27DC3904A74F51E9BC2630B93F6887E3F7CA1 | Rating Details |
2022-11-30 17:47:03 -0600 | CE7A15FC6D7E27AE4535CF8E7866ADD738EA534B09105096ABE6603813CDC872 | Rating Details |
2022-12-01 05:59:35 -0600 | D20F3D4EB9368E53F10790BE2B9B4C00F2D126901D1F22224F8CB71673146CAF | Rating Details |
2022-11-30 17:28:32 -0600 | D25A2B506DBF128EC1C18B1AEEE3AA97FFF91741AB302D97F628BBB1491F2F75 | Rating Details |
2022-11-30 15:20:46 -0600 | D48CB9A2C139A407A1445B0FA8CA287459C465ACD57E2435EE2BF57655577590 | Rating Details |
2022-11-30 17:55:26 -0600 | D4E80E5938EE94363F0E9B714E5C46F84034A4247D3F109FEC9727EDC0E1A824 | Rating Details |
2022-11-30 13:14:37 -0600 | D5A6A431C203F752BE53DD5E4049890DF3F9F01EA76DC7BDEAC3118EBA94B544 | Rating Details |
2022-11-30 17:29:07 -0600 | D6D045240A88D4F1FEE392E2494CBAFC538D3D9B1A516138EB0ADBA21FD736E3 | Rating Details |
2022-11-30 17:23:30 -0600 | D6EA5CB1192A90A9F0F3A56EC6AAA596C5BCB66B565AA674B656CF81AB53A2B8 | Rating Details |
2022-11-30 18:00:22 -0600 | DAE92584C54A7D539C15A7866514813E1EDE352276009592F71FDC03DD0AFD04 | Rating Details |
2022-11-30 10:09:57 -0600 | DBC322B9382DDED44E9CCC0019C17752740C91A86743EC20A05A6804A000E383 | Rating Details |
2022-11-30 18:25:44 -0600 | DCBC717505A66350E847896BA1C674AF15C115904EF013FB5885DFC64CA48B8A | Rating Details |
2022-11-30 17:53:51 -0600 | E46FB8D75B274A2FE2E5B850107BBED3CCB81E04EBE0222E458AC955550C178F | Rating Details |
2022-11-30 17:42:14 -0600 | E9C0872FD81D41DB8AF5D7CC7C18C094EE3B9170F02C2B44829D3330B4EAF814 | Rating Details |
2022-11-30 17:18:11 -0600 | EB181CBB07F21EE58A36DFB707C463E99C38860B9FFBAD8757D1C740A1907461 | Rating Details |
2022-11-30 18:09:52 -0600 | EE324E53713B71B86EC8589733024686766C983ED513834446ED0B8CE2B8B6D8 | Rating Details |
2022-11-30 17:53:52 -0600 | EE68B3E2724269871AB13B78EC3126748ADCB89C1A036C77D9117F534538CE24 | Rating Details |
2022-11-30 18:11:55 -0600 | EF8B73C6129C22CA7A58E3AC2330176889AB258508D86DAF2AF0A11E059278DC | Rating Details |
2022-11-30 17:29:11 -0600 | F029B2B586E3A0CC2D345A503DEE120FB643E40C414C8E39E7EC7269485B092A | Rating Details |
2022-11-30 17:32:05 -0600 | F16ADFD32D375B54C35A79E15CC143A58DE396E499B9915B23DF0FC60E9E30C8 | Rating Details |
2022-11-30 15:31:49 -0600 | F84750B2C2A0916992270B9ECEFB102695A95465CCFB3825153914DBB6F08EF0 | Rating Details |
2022-11-30 17:21:16 -0600 | FDA5DC737FE1BE0487A28D03903B6727D1EC070F662A2D816BFD7F8E065F2F04 | Rating Details |
2022-12-04 16:54:40 -0600 | Rating Details | |
2022-11-30 17:30:00 -0600 | Rating Details | |
2022-11-30 16:17:53 -0600 | Rating Details | |
2022-11-30 18:12:29 -0600 | Rating Details | |
2022-11-30 18:21:41 -0600 | Rating Details | |
2022-11-30 17:34:58 -0600 | Rating Details | |
2022-11-30 13:14:37 -0600 | Rating Details | |
2022-11-30 17:46:18 -0600 | Rating Details | |
2022-12-01 09:08:01 -0600 | Rating Details | |
2022-11-30 10:30:50 -0600 | Rating Details | |
2022-11-30 18:11:57 -0600 | Rating Details | |
2022-11-30 18:03:59 -0600 | Rating Details | |
2022-11-30 17:53:51 -0600 | Rating Details | |
2022-11-30 17:55:11 -0600 | Rating Details | |
2022-11-30 17:45:52 -0600 | Rating Details | |
2022-11-30 20:19:30 -0600 | Rating Details | |
2022-11-30 17:35:15 -0600 | Rating Details | |
2022-11-30 18:00:16 -0600 | Rating Details | |
2022-11-30 18:17:06 -0600 | Rating Details | |
2022-11-30 17:51:15 -0600 | Rating Details | |
2022-11-30 09:31:14 -0600 | Rating Details | |
2022-11-30 17:37:22 -0600 | Rating Details | |
2022-11-30 17:40:51 -0600 | Rating Details | |
2022-11-30 17:51:25 -0600 | Rating Details | |
2022-11-30 17:32:05 -0600 | Rating Details | |
2022-12-01 07:53:13 -0600 | Rating Details | |
2022-11-30 17:29:39 -0600 | Rating Details | |
2022-11-30 17:46:57 -0600 | Rating Details | |
2022-11-30 17:31:05 -0600 | Rating Details | |
2022-11-30 18:00:22 -0600 | Rating Details | |
2022-11-30 17:29:11 -0600 | Rating Details | |
2022-12-01 08:21:56 -0600 | Rating Details | |
2022-11-30 11:26:32 -0600 | Rating Details | |
2022-11-30 17:57:34 -0600 | Rating Details | |
2022-11-30 17:28:32 -0600 | Rating Details | |
2022-11-30 18:09:52 -0600 | Rating Details | |
2022-11-30 10:09:57 -0600 | Rating Details | |
2022-11-30 17:58:25 -0600 | Rating Details | |
2022-11-30 18:26:07 -0600 | Rating Details | |
2022-12-01 08:52:34 -0600 | Rating Details | |
2022-11-30 17:37:47 -0600 | Rating Details | |
2022-11-30 17:53:52 -0600 | Rating Details | |
2022-11-30 17:47:03 -0600 | Rating Details | |
2022-11-30 17:39:06 -0600 | Rating Details | |
2022-12-04 16:54:40 -0600 | Rating Details | |
2022-11-30 18:30:42 -0600 | Rating Details | |
2022-11-30 20:55:42 -0600 | Rating Details | |
2022-11-30 18:02:41 -0600 | Rating Details | |
2022-11-30 17:58:56 -0600 | Rating Details | |
2022-12-01 10:55:11 -0600 | Rating Details | |
2022-11-30 17:49:11 -0600 | Rating Details | |
2022-11-30 17:45:41 -0600 | Rating Details | |
2022-11-30 17:25:22 -0600 | Rating Details | |
2022-11-30 17:37:12 -0600 | Rating Details | |
2022-11-30 18:04:16 -0600 | Rating Details | |
2022-11-30 17:44:40 -0600 | Rating Details | |
2022-11-30 17:47:45 -0600 | Rating Details | |
2022-11-30 17:16:02 -0600 | Rating Details | |
2022-11-30 17:33:26 -0600 | Rating Details | |
2022-11-30 18:10:40 -0600 | Rating Details | |
2022-11-30 18:04:15 -0600 | Rating Details | |
2022-11-30 18:04:38 -0600 | Rating Details | |
2022-11-30 17:28:03 -0600 | Rating Details | |
2022-11-30 18:09:58 -0600 | Rating Details | |
2022-11-30 17:29:07 -0600 | Rating Details | |
2022-11-30 18:22:40 -0600 | Rating Details | |
2022-11-30 17:18:11 -0600 | Rating Details | |
2022-11-30 18:10:24 -0600 | Rating Details | |
2022-12-01 09:50:38 -0600 | Rating Details | |
2022-11-30 15:20:46 -0600 | Rating Details | |
2022-12-01 10:32:23 -0600 | Rating Details | |
2022-11-30 18:16:55 -0600 | Rating Details | |
2022-11-30 17:50:54 -0600 | Rating Details | |
2022-11-30 20:40:44 -0600 | Rating Details | |
2022-11-30 17:22:59 -0600 | Rating Details | |
2022-11-30 17:47:32 -0600 | Rating Details | |
2022-11-30 18:25:44 -0600 | Rating Details | |
2022-11-30 13:41:29 -0600 | Rating Details | |
2022-11-30 17:30:18 -0600 | Rating Details | |
2022-12-02 08:06:31 -0600 | Rating Details | |
2022-11-30 18:39:41 -0600 | Rating Details | |
2022-12-01 01:37:05 -0600 | Rating Details | |
2022-11-30 18:44:07 -0600 | Rating Details | |
2022-11-30 17:23:30 -0600 | Rating Details | |
2022-11-30 17:36:34 -0600 | Rating Details | |
2022-11-30 18:51:04 -0600 | Rating Details | |
2022-11-30 22:26:35 -0600 | Rating Details | |
2022-12-01 05:59:35 -0600 | Rating Details | |
2022-11-30 18:09:31 -0600 | Rating Details | |
2022-11-30 17:07:41 -0600 | Rating Details | |
2022-11-30 15:31:49 -0600 | Rating Details | |
2022-11-30 17:24:03 -0600 | Rating Details | |
2022-11-30 17:33:01 -0600 | Rating Details | |
2022-11-30 17:25:38 -0600 | Rating Details | |
2022-11-30 19:41:56 -0600 | Rating Details | |
2022-11-30 18:28:59 -0600 | Rating Details | |
2022-11-30 17:43:17 -0600 | Rating Details | |
2022-11-30 17:49:55 -0600 | Rating Details | |
2022-11-30 17:22:59 -0600 | Rating Details | |
2022-11-30 17:18:35 -0600 | Rating Details | |
2022-11-30 17:42:14 -0600 | Rating Details | |
2022-11-30 17:55:41 -0600 | Rating Details | |
2022-11-30 17:54:55 -0600 | Rating Details | |
2022-11-30 17:25:53 -0600 | Rating Details | |
2022-11-30 18:13:30 -0600 | Rating Details | |
2022-11-30 18:28:07 -0600 | Rating Details | |
2022-11-30 17:22:15 -0600 | Rating Details | |
2022-12-01 12:43:37 -0600 | Rating Details | |
2022-11-30 18:54:59 -0600 | Rating Details | |
2022-11-30 18:11:55 -0600 | Rating Details | |
2022-11-30 17:55:26 -0600 | Rating Details | |
2022-11-30 16:22:27 -0600 | Rating Details | |
2022-11-30 18:02:44 -0600 | Rating Details | |
2022-11-30 17:37:16 -0600 | Rating Details | |
2022-11-30 17:56:46 -0600 | Rating Details | |
2022-11-30 17:24:35 -0600 | Rating Details | |
2022-11-30 17:49:24 -0600 | Rating Details | |
2022-11-30 17:21:16 -0600 | Rating Details |